Various news outlets are reporting new statistics which indicate deaths from opioid overdose are beginning to go down.

The Associated Press reports that for the first time in a decade overdoses among New York residents (outside of NYC) have declined 15.9%. Government officials are quoted as saying that about 80% of the overdose deaths were attributable to heroin or fentanyl.

The AP cited a new CDC (Centers For Disease Control) July 2019 study which showed overdose deaths in 2018 fell for the first time in nearly three decades.

Various public education efforts and New York’s Opioid Task Force are thought to be significant catalysts for the slowdown in opioid overdoses. The availability of naloxone has also been highly instrumental in impacting overdoses nationwide with many communities across the country now providing naloxone kits for free.

A number of metro areas in the U.S. are also examining the feasibility of mobile opioid treatment since transportation to clinics or physicians is often an impediment to accessing medication-assisted treatment resources.

Behavioral Health Group (BHG) currently provides 54 top flight opioid addiction treatment centers in the United States. The company specializes in medication-assisted treatment using methadone, buprenorphine, and buprenorphine/naloxone.

BHG takes a patient-centered approach to treating addictive disorders offering counseling as a fundamental component of the overall treatment model. Because of this individualized treatment approach, 97% of patients surveyed indicate they would recommend BHG Recovery to a friend or family member suffering from opioid addiction.

Additionally, 99% of patients report that their mental health and quality of life improved since their BHG admission. 60% of unemployed patients were able to obtain employment after one year of treatment.

Hope, Respect, and Caring are tenets of BHG’s treatment program, and their staff strive to provide this from the moment a patient first walks in to receive help. All of BHG’s treatment centers provide care in an outpatient setting.

In 2019, BHG Recovery added (6) additional U.S. clinics to the Methadone.US national directory list …

1. Franklin, VA – BHG Franklin Treatment Center
2. Chesapeake, VA – BHG Chesapeake South Treatment Center
3. Glen Allen, VA – BHG Glen Allen Treatment Center
4. Mobile, AL – BHG Mobile Treatment Center
5. Cullman, AL – BHG Cullman Treatment Center
6. Washington, DC – BHG Washington DC Treatment Center

Acadia Healthcare is a leading provider of addiction treatment and behavioral healthcare services in the USA, the UK, and Puerto Rico. Worldwide, they operate a network of 593 facilities with 18,100 beds in 40 U.S. States. Of these locations, Acadia offer medication-assisted opioid treatment in 127 of their facilities.

In 2019, Acadia added 11 additional U.S. clinics to the Methadone.US national directory list …

1. Aberdeen, WA – Grays Harbor Treatment Solutions
2. Escondido, CA – Mission Treatment Services of Escondido
3. Henderson, NV – Mission Treatment Center of Henderson
4. Las Vegas, NV – Mission Treatment Center of Las Vegas
5. Mansfield, OH – Mansfield Comprehensive Treatment Center
6. Oceanside, CA – Mission Treatment Services of Oceanside
7. Oklahoma City, OK – Mission Treatment Center of Hefner
8. Oklahoma City, OK – Mission Treatment Center of Oklahoma City
9. San Diego, CA – Mission Treatment Services of Clairemont Mesa
10. Scottsdale, AZ – Mission Treatment Center of Scottsdale
11. Tulsa, OK – Mission Treatment Center of Oklahoma City

While Acadia are experts in the treatment of opioid misuse disorders, they treat a wide variety of addiction-related problems utilizing traditional outpatient programs up to inpatient detoxification and residential treatment. You can view Acadia’s Levels of Care descriptions to gain a better view of the breadth of their substance abuse services.

Here is a complete listing of Acadia opioid treatment clinics.

Recovery from opioid addiction initially centers around physical stabilization: specifically the management of opioid withdrawal. This is an essential step for the vast majority of opioid addicted people seeking help. Research has shown a 90% failure rate for opioid treatment programs that do not offer medication assistance.

Methadone was the original medication FDA-approved for treating opioid addiction although Subutex has been recently introduced into opioid treatment programs around the country as a viable alternative. Subutex is effective especially for milder levels of opioid dependency.

Subutex is a brand name version of buprenorphine, the partial opioid agonist that reduces withdrawal symptom sickness. Most patients are familiar with “Suboxone” which is a popular buprenorphine-based film that is dissolved under the tongue and is taken once per day. It differs from Subutex in that it contains naloxone so that it cannot be easily abused intravenously.

A number of methadone clinics began offering subutex in the past few years in an effort to expand treatment options for patients. Because subutex can be abused, it is typically administered daily in the clinic by a nurse where it can be supervised.

If you are considering entering a treatment program for opioid misuse, you may want to ask about the variety of medications utilized by the clinic or physician. Some patients have successfully transitioned from methadone to subutex while others enter the program starting with subutex. This is a decision best made in conjunction with your treating doctor who can formulate a treatment plan based on your history of opioid use.